Benzinga | Aug 10, 2020 04:30PM EDT

Homology Medicines Q2 EPS $(0.78) Down From $(0.61) YoY, Sales $567.00K Up From $392.00K YoY

Homology Medicines (NASDAQ:FIXX) reported quarterly losses of $(0.78) per share. This is a 27.87 percent decrease over losses of $(0.61) per share from the same period last year. The company reported $567.00 thousand in sales this quarter. This is a 44.64 percent increase over sales of $392.00 thousand the same period last year.